期刊文献+

应用分子伴侣探索e23sFv/His融合蛋白的可溶性表达 被引量:2

Application of molecular chaperones to soluble expression of e23sFv/His fusion proteins
下载PDF
导出
摘要 目的探讨利用分子伴侣实现e23sFv/His融合蛋白可溶性表达的可行性。方法将分子伴侣质粒pGro7、pKJE7与e23sFv原核表达载体共转化BL21(DE3)感受态细胞。16℃诱导融合蛋白可溶性表达,比较可溶性表达产物相对于常规包涵体不溶形式表达产物在产量和抗原结合活性方面的差异。结果可溶性表达的e23sFv/His产量较小,纯化得率低,其抗原结合活性没有明显优于包涵体表达纯化产物。结论应用pGro7、pKJE7有助于e23sFv/His融合蛋白的可溶性表达,但其表达和纯化得率较低。 Objective To explore the feasibility of applying molecular chaperones to the soluble expression of e23sFv/His fusion proteins. Methods The molecular chaperone plasmid pGro7 or pKJE7 was transformed into BL21( DE3) competent cells together with the prokaryotic expression vector harboring His-tagged e23sFv. The soluble expression of e23sFv / His proteins was induced at 16℃. The yield and antigen-binding activity of the soluble products were compared with those of the insoluble products conventionally purified from inclusion bodies. Results Both the overall yield and the purification ratio of soluble e23sFv / His proteins were relatively lower. The binding affinity of the soluble products to immobilized HER2 was not superior to that of the insoluble products from inclusion bodies. Conclusion The molecular chaperone plasmids pGro7 and pKJE7 partially facilitate the soluble expression of e23sFv / His proteins,but both the yield and the purification ratio are stil limited.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2015年第9期1205-1210,共6页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81372459)
关键词 e23sFv 可溶性表达 分子伴侣 e23 single-chain Fv fragment(e23sFv) soluble expression molecular chaperone
  • 相关文献

参考文献4

二级参考文献51

  • 1萨姆布鲁克J,拉塞尔D W,黄培堂,王嘉玺,朱厚础,等译.分子克隆实验指南[M]3版.北京:科学出版社,2002..
  • 2Azar Y, Lorberboum GH. GnRH2Bik/Bax/Bak chimeric proteins target and kill adenoearcinoma cells : the general use of pro-apoptotic pro- reins of the Bcl-2 family as novel killing components of targeting chim- eric protei-ns[J]. Apoptosis, 2000, 5(6): 531 -542.
  • 3Jia LT, Zhang LH, Yu CJ, et al. Specific tumouricidal activity of a secreted pro-apoptotic protein consisting of HER2 antibody and consti- tutively active caspase-3[ J]. Cancer Res, 2003, 63 (12) : 3257 - 3262.
  • 4Xu YM, Wang LF, Jia LT, et al. A caspase-6 and anti-human epider- mal growth factor receptor-2 ( HER2 ) antibody chimeric molecuLe sup- presses the growth of HER2-overexpressing turnouts [ J ]. J Immunol, 2004, 173(1) : 61 -67.
  • 5Zhao J, Zhang LH, Jia LT, et al. Secreted antibody/granzyme B fu- sion protein stimp~Lates selective killing of HER.2-overexpressing turnout cells[J]. J Biol Chem, 2004, 279(20) : 21343 -21348.
  • 6Yu CJ, Jia LT, Meng YL, et al. Selective pro-apoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2[J]. Gene Ther, 2006, 13(4) : 313 -320.
  • 7Wang F, Ren J, Qiu XC, et al..Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence[J]. Clin Cancer Res, 2010, 16(8) : 2284 -2294.
  • 8Sauer B. Site-specific recombination: developments and application [ J ]. Curr Opin Biotechnol, 1994, 5 (5) : 521 - 527.
  • 9Buchholz F, Ringrose L, Angrand PO, et al. Different thermostabili- ties of FLP and Cre recombinases : Implications or applied site-specific recombination [ J ]. Nuc Acids Res, 1996, 24 (21) : 4256 - 4262.
  • 10Collier RJ. Understanding the mode of action of diphtheria toxin:a prospective on progress during the 20th century [J]. Toxicon, 2001, 39: 1793-1803.

共引文献6

同被引文献8

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部